Pharmaco-EEG profiles of typical and atypical antidepressants.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Advances in biochemical psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7090895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluvoxamine—A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

  2005cited by this paper
• Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.

  1980cited by this paper
• Development of a classification rule for four clinical therapeutic psychotropic drug classes with EEG power-spectrum variables of human volunteers.

  1979cited by this paper
• Tandamine--a new norepinephrine reuptake inhibitor. Clinical, psychometric and quantitative EEG studies in depressed patients.

  1977cited by this paper
• Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects.

  1976cited by this paper
• Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.

  1976cited by this paper
• Relationship between the pharmacokinetics and pharmacodynamics of procainamide

  1976cited by this paper
• Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

  1972cited by this paper
• Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.

  1969cited by this paper
• EEG and human psychopharmacology.

  1969cited by this paper

• Pharmaco-Electroencephalography-Based Assessment of Antidepressant Drug Efficacy—The Use of Magnesium Ions in the Treatment of Depression

  2021cites this paper
• Brain Monitoring Devices in Neuroscience Clinical Research: The Potential of Remote Monitoring Using Sensors, Wearables, and Mobile Devices

  2018cites this paper
• Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats

  2014cites this paper
• EEG Topography and Tomography (LORETA) in Diagnosis and Pharmacotherapy of Depression

  2010cites this paper
• Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers

  2009cites this paper
• Trazodona combinada con ISRS e ISRN en pacientes deprimidos que presentan ansiedad e insomnio

  2007cites this paper
• Psychotropic Profile of S 17092, a Prolyl Endopeptidase Inhibitor, Using Quantitative EEG in Young Healthy Volunteers

  2007cites this paper
• Pharmaco-EEG in Psychiatry

  2006cites this paper
• On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine

  2005cites this paper
• Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and — inhibiting fluvoxamine utilizing EEG mapping and psychometry

  2005cites this paper
• Insomnia in Somatoform Pain Disorder: Sleep Laboratory Studies on Differences to Controls and Acute Effects of Trazodone, Evaluated by the Somnolyzer 24 × 7 and the Siesta Database

  2005cites this paper
• Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.

  2005cites this paper
• EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers

  2004cites this paper
• Confirmation of the Neurophysiologically Predicted Therapeutic Effects of Trazodone on Its Target Symptoms Depression, Anxiety and Insomnia by Postmarketing Clinical Studies with a Controlled-Release Formulation in Depressed Outpatients

  2003cites this paper
• Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry

  2002cites this paper
• Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).

  2002cites this paper
• Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.

  2002cites this paper
• EEG correlates of acute and chronic paroxetine treatment in depression.

  2002cites this paper
• Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.

  2002cites this paper
• Localization of MDMA‐induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

  2001influential citation
• Insomnia Related to Dysthymia: Polysomnographic and Psychometric Comparison with Normal Controls and Acute Therapeutic Trials with Trazodone

  2001cites this paper
• Quantitative EEG in Frontotemporal Dementia

  1996cites this paper
• Induction of sleep.

  1996cites this paper
• Effects of [des-Tyr-D-Phe3]beta-casomorphin (2-5) on cortical EEG power spectra in rats.

  1994cites this paper
• Effects of tianeptine on sleep-wakefulness cycles in the rhesus monkey

  1993cites this paper
• PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY.

  1992cites this paper
• On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies.

  1990cites this paper
• Neuromonitoring in High Risk Surgery: Physiological Tolerance Limits for Central Nervous System

  1989cites this paper
• Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).

  1988cites this paper
• Second-Generation Antidepressants

  1987cites this paper
• Comparative Placebo-controlled Pharmacodynamic Studies with Zotepine and Clozapine Utilizing Pharmaco-EEG and Psychometry

  1987cites this paper
• On the central effects of the GABA agonist fengabine: Psychometric and pharmaco‐EEG studies utilizing imaging methods

  1987cites this paper
• EEG, EEG Power Spectra, and Behavioral Correlates of Opioids and Other Psychoactive Agents

  1987cites this paper
• Zur Bestimmung der Pharmakodynamik alter und neuer Benzodiazepine mittels des Pharmako-EEGs

  1986cites this paper
• Use of specific serotonin uptake inhibitors as antidepressants.

  1985cites this paper
• Determination of Pharmacokinetics and Pharmacodynamics of Amisulpride by Pharmaco-EEG and Psychometry

  1985cites this paper
• Early clinical pharmacological studies with sercloremine—a novel antidepressant—utilizing pharmacokinetic, pharmaco‐EEG, and psychometric analyses

  1985cites this paper
• Examining Pharmaco EEG-Based Predictions about the Antidepressant Action of Pirlindol by Double Blind Clinical Trials

  1985cites this paper
• Zur zentralen Wirkung hoher Benzodiazepindosen: Quantitative Pharmako-EEG- und psychometrische Studien mit Prazepam

  1984cites this paper
• Quantitative pharmaco-EEG and performance after administration of brotizolam to healthy volunteers.

  1983cites this paper